Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. United States Generic Drugs Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Small Molecule Generics, Biosimilars)
5.2.2. By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Infectious Diseases, Others)
5.2.3. By Mode of Drug Delivery (Oral, Topical, Parenteral, Others)
5.2.4. By Form (Tablet, Capsule, Injection, Others)
5.2.5. By Source (In House, Contract Manufacturing Organizations)
5.2.6. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others)
5.2.7. By Region
5.2.8. By Company (2022)
5.3. Market Map
6. North-East Generic Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Application
6.2.3. By Mode of Drug Delivery
6.2.4. By Form
6.2.5. By Source
6.2.6. By Distribution Channel
7. Mid-West Generic Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Application
7.2.3. By Mode of Drug Delivery
7.2.4. By Form
7.2.5. By Source
7.2.6. By Distribution Channel
8. West Generic Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Application
8.2.3. By Mode of Drug Delivery
8.2.4. By Form
8.2.5. By Source
8.2.6. By Distribution Channel
9. South Generic Drugs Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Application
9.2.3. By Mode of Drug Delivery
9.2.4. By Form
9.2.5. By Source
9.2.6. By Distribution Channel
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
11.1. Recent Development
11.2. Mergers & Acquisitions
11.3. Product Launches
12. Policy & Regulatory Landscape
13. United States Economic Profile
14. United States Generic Drugs Market: SWOT Analysis
15. Porter’s Five Forces Analysis
15.1. Competition in the Industry
15.2. Potential of New Entrants
15.3. Power of Suppliers
15.4. Power of Customers
15.5. Threat of Substitute Products
16. Competitive Landscape
16.1. Teva Pharmaceuticals USA, Inc.
16.1.1. Business Overview
16.1.2. Product Offerings
16.1.3. Recent Developments
16.1.4. Financials (As Reported)
16.1.5. Key Personnel
16.2. Pfizer Inc.
16.3. Sandoz US
16.4. Endo International plc
16.5. Aurobindo Pharma USA, Inc.
16.6. Abbott Laboratories Inc.
16.7. Eli Lilly and Company
16.8. Sun Pharma USA
16.9. Lupin Pharmaceuticals, Inc.
16.10. Zydus Pharmaceuticals USA
17. Strategic Recommendations
18. About Us & Disclaimer